These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9594937)

  • 1. Systemic antifungal agents used to treat onychomycosis.
    Katz HI
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S48-52. PubMed ID: 9594937
    [No Abstract]   [Full Text] [Related]  

  • 2. Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.
    Evans EG
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S32-36. PubMed ID: 9594934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole versus terbinafine in the management of onychomycosis: an overview.
    Jain S; Sehgal VN
    J Dermatolog Treat; 2003 Jan; 14(1):30-42. PubMed ID: 12745853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 7. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
    Bonifaz A; Paredes V; Fierro L
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):699-700. PubMed ID: 17447997
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
    Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
    Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis. New therapies for an old disease.
    Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
    West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials.
    Krob AH; Fleischer AB; D'Agostino R; Feldman SR
    J Cutan Med Surg; 2003; 7(4):306-11. PubMed ID: 14738099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis treated with a short course of oral terbinafine.
    Galimberti R; Kowalczuk A; Flores V; Squiquera L
    Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
    Heikkilä H; Stubb S
    Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole: an effective oral antifungal for onychomycosis.
    Jain S; Sehgal VN
    Int J Dermatol; 2001 Jan; 40(1):1-5. PubMed ID: 11277944
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.
    Chiu HY; Chang WL; Tsai TF; Tsai YW; Shiu MN
    Drug Saf; 2018 Mar; 41(3):285-295. PubMed ID: 29110252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.